Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma

Journal of Pathology

Volumn 231, Issue 2, 2013, Pages 257-270

  Fang, Wang Kai ^a   Liao, Lian Di ^a   Li, Li Yan ^a   Xie, Yang Min ^a   Xu, Xiu E ^a   Zhao, Wei Jiang ^a   Wu, Jian Yi ^a   Zhu, Meng Xiao ^a   Wu, Zhi Yong ^a   Du, Ze Peng ^a   Wu, Bing Li ^a   Xie, Dong ^b   Guo, Ming Zhou ^c   Xu, Li Yan ^a   Li, En Min ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

DSC2; E cadherin; invasion; miR 25; oesophageal squamous cell carcinoma

Indexed keywords

BETA CATENIN; DESMOCOLLIN; MESSENGER RNA; PLAKOGLOBIN; UVOMORULIN;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CANCER PROGNOSIS; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION;

EID: 84883894502     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4236     Document Type: Article

References (49)

1. Kamangar F, Dores GM, Anderson WF,. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
2. Mariette C, Balon JM, Piessen G, et al., Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003; 97: 1616-1623.
3. Green KJ, Getsios S, Troyanovsky S, et al., Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol 2010; 2: a000125.
4. Wijnhoven BP, Dinjens WN, Pignatelli M,. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000; 87: 992-1005.
5. Takayama N, Arima S, Haraoka S, et al., Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes. Anticancer Res 2003; 23: 4435-4442.
6. Takeno S, Noguchi T, Fumoto S, et al., E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications. Am J Clin Pathol 2004; 122: 78-84.
7. Jeanes A, Gottardi CJ, Yap AS,. Cadherins and cancer: how does cadherin dysfunction promote tumour progression? Oncogene 2008; 27: 6920-6929.
8. Garrod D, Chidgey M,. Desmosome structure, composition and function. Biochim Biophys Acta 2008; 1778: 572-587.
9. Green KJ, Simpson CL,. Desmosomes: new perspectives on a classic. J Invest Dermatol 2007; 127: 2499-2515.
10. Chun MG, Hanahan D,. Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis. PLoS Genet 2010; 6: e1001120.
11. Nuber UA, Schäfer S, Schmidt A, et al., The widespread human desmocollin Dsc2 and tissue-specific patterns of synthesis of various desmocollin subtypes. Eur J Cell Biol 1995; 66: 69-74.
12. Khan K, Hardy R, Haq A, et al., Desmocollin switching in colorectal cancer. Br J Cancer 2006; 95: 1367-1370.
13. Kolegraff K, Nava P, Helms MN, et al., Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell 2011; 22: 1121-1134.
14. Hamidov Z, Altendorf-Hofmann A, Chen Y, et al., Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. J Clin Pathol 2011; 64: 990-994.
15. Hayashi T, Sentani K, Oue N, et al., Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma. Histopathology 2011; 59: 710-721.
16. Fang WK, Gu W, Li EM, et al., Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor. Hum Pathol 2010; 41: 1456-1465.
17. Department of Cell Biology of CICAMS. Establishment of an epithelial cell line from human esophageal carcinoma. Chin Med J (Engl) 1976; 2: 357-364.
18. Shimada Y, Imamura M, Wagata T, et al., Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992; 69: 277-284.
19. Shen Z, Cen S, Shen J, et al., Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7. J Cancer Res Clin Oncol 2000; 126: 589-594.
20. Korinek V, Barker N, Morin PJ, et al., Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-1787.
21. Zoumalan RA, Kleinberger AJ, Morris LG, et al., Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: pilot study. J Laryngol Otol 2010; 124: 1284-1288.
22. Imre K, Pinar E, Oncel S, et al., Predictors of extracapsular spread in lymph node metastasis. Eur Arch Otorhinolaryngol 2008; 265: 337-339.
23. Hardman MJ, Liu K, Avilion AA, et al., Desmosomal cadherin misexpression alters beta-catenin stability and epidermal differentiation. Mol Cell Biol 2005; 25: 969-978.
24. Miravet S, Piedra J, Castaño J, et al., Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates beta-catenin-mediated transcription. Mol Cell Biol 2003; 23: 7391-7402.
25. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, et al., Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 2002; 16: 2058-2072.
26. Chan JY, Ong CW, Salto-Tellez M,. Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer. Cancer Sci 2011; 102: 1855-1861.
27. Gu ZD, Li JY, Li M, et al., Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005; 100: 1835-1843.
28. Bosch FX, Andl C, Abel U, et al., E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int J Cancer 2005; 114: 779-790.
29. Oshiro MM, Kim CJ, Wozniak RJ, et al., Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res 2005; 7: R669-R680.
30. Cho WC,. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60.
31. Valastyan S, Weinberg RA,. Roles for microRNAs in the regulation of cell adhesion molecules. J Cell Sci 2011; 124: 999-1006.
32. Wu BL, Xu LY, Du ZP, et al., MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol 2011; 17: 79-88.
33. van Zijl F, Krupitza G, Mikulits W,. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 2011; 728: 23-34.
34. Heuberger J, Birchmeier W,. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010; 2: a002915.
35. Fodde R, Brabletz T,. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19: 150-158.
36. Markowitz SD, Bertagnolli MM,. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-2460.
37. Ninomiya I, Endo Y, Fushida S, et al., Alteration of beta-catenin expression in esophageal squamous-cell carcinoma. Int J Cancer 2000; 85: 757-761.
38. Zhang G, Zhou X, Xue L, et al., Accumulation of cytoplasmic beta-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: immunohistochemical study. Pathol Int 2005; 55: 310-317.
39. Kimura Y, Shiozaki H, Doki Y, et al., Cytoplasmic beta-catenin in esophageal cancers. Int J Cancer 1999; 84: 174-178.
40. de Castro J, Gamallo C, Palacios J, et al., Beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. Virchows Arch 2000; 437: 599-604.
41. Huen AC, Park JK, Godsel LM, et al., Intermediate filament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol 2002; 159: 1005-1017.
42. Vasioukhin V, Bowers E, Bauer C, et al., Desmoplakin is essential in epidermal sheet formation. Nature Cell Biol 2001; 3: 1076-1085.
43. Zhang J, Ma L,. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 2012; 31: 653-662.
44. Poliseno L, Salmena L, Riccardi L, et al., Identification of the miR-106b ∼ 25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010; 3: ra29.
45. Mulholland DJ, Kobayashi N, Ruscetti M, et al., Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 2012; 72: 1878-1889.
46. Xu X, Chen Z, Zhao X, et al., MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem Biophys Res Commun 2012; 421: 640-645.
47. Suh SS, Yoo JY, Nuovo GJ, et al., MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A 2012; 109: 5316-5321.
48. Xie JJ, Xu LY, Wu JY, et al., Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol 2010; 176: 939-951.
49. Cui L, Xu LY, Shen ZY, et al., NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma. Clin Cancer Res 2008; 14: 7674-7681.